Unknown

Dataset Information

0

Cancer-cell-secreted miR-122 suppresses O-GlcNAcylation to promote skeletal muscle proteolysis.


ABSTRACT: A decline in skeletal muscle mass and low muscular strength are prognostic factors in advanced human cancers. Here we found that breast cancer suppressed O-linked N-acetylglucosamine (O-GlcNAc) protein modification in muscle through extracellular-vesicle-encapsulated miR-122, which targets O-GlcNAc transferase (OGT). Mechanistically, O-GlcNAcylation of ryanodine receptor 1 (RYR1) competed with NEK10-mediated phosphorylation and increased K48-linked ubiquitination and proteasomal degradation; the miR-122-mediated decrease in OGT resulted in increased RYR1 abundance. We further found that muscular protein O-GlcNAcylation was regulated by hypoxia and lactate through HIF1A-dependent OGT promoter activation and was elevated after exercise. Suppressed O-GlcNAcylation in the setting of cancer, through increasing RYR1, led to higher cytosolic Ca2+ and calpain protease activation, which triggered cleavage of desmin filaments and myofibrillar destruction. This was associated with reduced skeletal muscle mass and contractility in tumour-bearing mice. Our findings link O-GlcNAcylation to muscular protein homoeostasis and contractility and reveal a mechanism of cancer-associated muscle dysregulation.

SUBMITTER: Yan W 

PROVIDER: S-EPMC9107513 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

altmetric image

Publications


A decline in skeletal muscle mass and low muscular strength are prognostic factors in advanced human cancers. Here we found that breast cancer suppressed O-linked N-acetylglucosamine (O-GlcNAc) protein modification in muscle through extracellular-vesicle-encapsulated miR-122, which targets O-GlcNAc transferase (OGT). Mechanistically, O-GlcNAcylation of ryanodine receptor 1 (RYR1) competed with NEK10-mediated phosphorylation and increased K48-linked ubiquitination and proteasomal degradation; the  ...[more]

Similar Datasets

2023-03-10 | PXD021232 | Pride
| S-EPMC6881278 | biostudies-literature
| S-EPMC4380143 | biostudies-literature
| S-EPMC10987463 | biostudies-literature
| S-EPMC5992481 | biostudies-literature
| S-EPMC5365311 | biostudies-literature
| S-EPMC10950823 | biostudies-literature
| S-EPMC10717412 | biostudies-literature
| S-EPMC9180116 | biostudies-literature
| S-EPMC8653916 | biostudies-literature